AMGN News Alert Amgen Inc (AMGN) 153.48 02/14/2015 11:29:44

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:29 PM

Amgen Inc (AMGN) 153.48 $AMGN

Coherus BioSciences: A Sharp Increase, A Sharp Drop, Plus Collateral News Creates A Buying Opportunity
Regarded Solutions - at Seeking Alpha - 2 hrs 38 mins ago

JNJ: 99.62 (+1.18), BAX: 70.39 (+0.31), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), HSP: 87.35 (unch), CHRS: 27.11 (-0.71)

Final Glance: Biotechnology companies
AP - Fri Feb 13, 5:13PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
AMGN: 153.48 (+0.30)

Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)

Midday Glance: Biotechnology companies
AP - Fri Feb 13, 12:23PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)

Why Shares of Cytokinetics Incorporated Skyrocketed
George Budwell, The Motley Fool - Motley Fool - Fri Feb 13, 11:44AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of the clinical-stage biopharma Cytokinetics ...
CYTK: 7.78 (+1.29), AMGN: 153.48 (+0.30)

Early Glance: Biotechnology companies
AP - Fri Feb 13, 10:05AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), CELG: 115.88 (+0.16)

1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)

What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics
PR Newswire - Fri Feb 13, 6:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
AGTC: 24.49 (-0.19), APTO: 4.65 (+0.43), AMGN: 153.48 (+0.30), ATRA: 18.00 (-0.10), ARIA: 7.35 (+0.45)

Amgen's Skin Cancer Drug to Face FDA Advisory Panel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 3:10PM CST
Amgen's (AMGN) experimental skin cancer treatment, talimogene laherparepvec, is scheduled to face twin FDA advisory committees on Apr 29, 2015.
BMRN: 100.76 (+1.98), KITE: 62.59 (+0.82), MRK: 58.81 (-0.07), AMGN: 153.48 (+0.30)

Why Regeneron's Risk-Reward Looks Good Again
DoctoRx - at Seeking Alpha - Thu Feb 12, 12:43PM CST

PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), AMGN: 153.48 (+0.30), LLY: 70.56 (+0.03), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)

Biosimilar firms up on Remicade patent rejection
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:56AM CST

JNJ: 99.62 (+1.18), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), EPRS: 7.67 (+0.67), PFNX: 12.45 (+0.29), HSP: 87.35 (unch), NVS: 102.20 (-0.17), CHRS: 27.11 (-0.71)

Amgen: A Dividend Growing Powerhouse In My Portfolio
Roadmap2Retire - Seeking Alpha - Thu Feb 12, 9:01AM CST
The stock market isn't providing good discounts especially in quality names, but at least the return of volatility is providing some opportunities for investors, as the traders speculate sending the market up and down. It is hard to find decent value...
AMGN: 153.48 (+0.30)

Forget Gilead Sciences: Here Are 3 Better Biotech Stocks
Motley Fool Staff - Motley Fool - Thu Feb 12, 7:19AM CST
A doubling of Gilead Sciences ' sales has given investors plenty of reason to cheer on the biotech Goliath over the past year. However, with Gilead Sciences' sales growth set to slow this year, investors may find that these three top biotech stocks...
BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)

Amgen's PDUFA date for melanoma drug BLA pushed out three months
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:27AM CST

AMGN: 153.48 (+0.30)

Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)

'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)

Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truck Drivers USA & Career Driver Unveil New Driver Agent

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Gourmia Introduces Ceramic-Coated Air Fryer at Costco

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

Dr. Anderson’s Journey: Leadership with Faith and Service

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

Canada and Ukraine Fortify Defense with UGV Partnership

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Marshall Goldman Expands Footprint with Marino Acquisition

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Cogent Communications' Q3 2026 Earnings Call Details

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...